Litcius/Paper detail

2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients

John K. Forrest, G. Michael Deeb, Steven J. Yakubov, Joshua D. Rovin, Mubashir Mumtaz, Hemal Gada, Daniel O’Hair, Tanvir Bajwa, Paul Sorajja, John Heiser, William Merhi, Abeel A. Mangi, Douglas Spriggs, Neal S. Kleiman, Stanley Chetcuti, Paul S. Teirstein, George L. Zorn, Peter Tadros, Didier Tchétché, Jon R. Resar, Antony Walton, Thomas G. Gleason, Basel Ramlawi, Ayman Iskander, Ronald Caputo, Jae K. Oh, Jian Huang, Michael J. Reardon

2022Journal of the American College of Cardiology90 citationsDOI

Topics & Concepts

MedicineClinical endpointValve replacementStroke (engine)StenosisAortic valve stenosisSurgeryCardiologyAortic valve replacementInternal medicineRandomized controlled trialMechanical engineeringEngineeringCardiac Valve Diseases and TreatmentsAortic Disease and Treatment ApproachesCardiovascular Function and Risk Factors
2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients | Litcius